hyper-CVAD
Term · Oncology and biomedicine · MLC-T-ONC-004059
An abbreviation for a chemotherapy combination used to treat some types of acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL). Hyper-CVAD includes the drugs cyclophosphamide, vincristine sulfate, doxorubicin hydrochloride (Adriamycin), and dexamethasone. It also includes the drugs methotrexate and cytarabine. It is given as hyperfractionated therapy, in which the total dose of the drugs is divided into small doses and given more than once a day. Also called hyper-CVAD regimen.
| Identifier | MLC-T-ONC-004059 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | hyper-CVAD regimen |
| References | NCI Dictionary of Cancer Terms |
Record as JSON
{
"id": "MLC-T-ONC-004059",
"term": "hyper-CVAD",
"field": "Oncology and biomedicine",
"definition": "An abbreviation for a chemotherapy combination used to treat some types of acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL). Hyper-CVAD includes the drugs cyclophosphamide, vincristine sulfate, doxorubicin hydrochloride (Adriamycin), and dexamethasone. It also includes the drugs methotrexate and cytarabine. It is given as hyperfractionated therapy, in which the total dose of the drugs is divided into small doses and given more than once a day. Also called hyper-CVAD regimen.",
"synonyms": [
"hyper-CVAD regimen"
],
"references": [
"NCI Dictionary of Cancer Terms"
],
"url": "https://mlchart.com/terminology/oncology/hyper-cvad/"
}
Record 8,820 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.